Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D02WST
|
||||
Former ID |
DIB009429
|
||||
Drug Name |
Unfractionated heparin
|
||||
Synonyms |
Elaprin; UFH (solid oral), Emisphere; Unfractionated heparin (solid oral, eligen); SNAC/heparin capsule (solid oral), Emisphere; SNAD/heparin tablet (solid oral), Emisphere; Unfractionated heparin (solid oral, eligen), Emisphere
|
||||
Company |
Emisphere Technologies Inc
|
||||
Target and Pathway | |||||
Target(s) | Antithrombin-III | Target Info | Modulator | [533572] | |
KEGG Pathway | Complement and coagulation cascades | ||||
PANTHER Pathway | Blood coagulation | ||||
Pathway Interaction Database | Glypican 1 network | ||||
References | |||||
Ref 526268 | Bivalirudin as a replacement for unfractionated heparin in unstable angina/non-ST-elevation myocardial infarction: observations from the TIMI 8 trial. The Thrombolysis in Myocardial Infarction. Am Heart J. 2002 Feb;143(2):229-34. | ||||
Ref 549902 | Clinical pipeline report, company report or official report of Emisphere Technologies. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.